| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.009 |